Bluejay Diagnostics Inc (NASDAQ: BJDX) is -99.24% lower on its value in year-to-date trading and has touched a low of $0.07 and a high of $31.28 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BJDX stock was last observed hovering at around $0.10 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $0.07, the stock is -24.56% and -38.10% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.14 million and changing -28.85% at the moment leaves the stock -97.30% off its SMA200. BJDX registered -99.73% loss for a year compared to 6-month loss of -98.39%. The firm has a 50-day simple moving average (SMA 50) of $0.12118 and a 200-day simple moving average (SMA200) of $2.772705.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -28.85% gain in the last 1 month and extending the period to 3 months gives it a -72.39%, and is -20.09% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 22.93% over the week and 28.20% over the month.
Bluejay Diagnostics Inc (BJDX) has around 10 employees, a market worth around $1.99M and $0.00M in sales. Distance from 52-week low is 1.65% and -99.76% from its 52-week high. The company has generated returns on investments over the last 12 months (-117.58%).
4.0 institutions hold shares in Bluejay Diagnostics Inc (BJDX), with institutional investors hold 0.96% of the company’s shares. The shares outstanding are 26.88M, and float is at 26.75M with Short Float at 0.08%. Institutions hold 0.95% of the Float.
Bluejay Diagnostics Inc (BJDX) Insider Activity
The most recent transaction is an insider purchase by Dey Svetlana, the company’s Director. SEC filings show that Dey Svetlana bought 500 shares of the company’s common stock on Dec 13 ’23 at a price of $3.07 per share for a total of $1535.0. Following the purchase, the insider now owns 1500.0 shares.
Bluejay Diagnostics Inc disclosed in a document filed with the SEC on Dec 13 ’23 that Dey Indranil (President and CEO) bought a total of 500 shares of the company’s common stock. The trade occurred on Dec 13 ’23 and was made at $3.27 per share for $1635.0. Following the transaction, the insider now directly holds 28526.0 shares of the BJDX stock.
